
### [NCIT:C4436](http://purl.obolibrary.org/obo/NCIT_C4436)
**Label:** Cholangiocarcinoma

**Subclasses:** [NCIT:C134751](http://purl.obolibrary.org/obo/NCIT_C134751) (Stage IV Hilar Cholangiocarcinoma AJCC v8), [NCIT:C134756](http://purl.obolibrary.org/obo/NCIT_C134756) (Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134514](http://purl.obolibrary.org/obo/NCIT_C134514) (Intrahepatic Cholangiocarcinoma by AJCC v7 Stage), [NCIT:C134755](http://purl.obolibrary.org/obo/NCIT_C134755) (Intrahepatic Cholangiocarcinoma by AJCC v8 Stage), [NCIT:C41619](http://purl.obolibrary.org/obo/NCIT_C41619) (Signet Ring Cell Intrahepatic Cholangiocarcinoma), [NCIT:C41618](http://purl.obolibrary.org/obo/NCIT_C41618) (Mucin-Producing Intrahepatic Cholangiocarcinoma), [NCIT:C41617](http://purl.obolibrary.org/obo/NCIT_C41617) (Cholangiolocellular Carcinoma), [NCIT:C128807](http://purl.obolibrary.org/obo/NCIT_C128807) (Recurrent Intrahepatic Cholangiocarcinoma), [NCIT:C43848](http://purl.obolibrary.org/obo/NCIT_C43848) (Clear Cell Intrahepatic Cholangiocarcinoma), [NCIT:C88049](http://purl.obolibrary.org/obo/NCIT_C88049) (Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C88060](http://purl.obolibrary.org/obo/NCIT_C88060) (Stage II Hilar Cholangiocarcinoma AJCC v7), [NCIT:C134757](http://purl.obolibrary.org/obo/NCIT_C134757) (Stage I Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C35417](http://purl.obolibrary.org/obo/NCIT_C35417) (Intrahepatic Cholangiocarcinoma), [NCIT:C134761](http://purl.obolibrary.org/obo/NCIT_C134761) (Stage III Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134760](http://purl.obolibrary.org/obo/NCIT_C134760) (Stage II Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134745](http://purl.obolibrary.org/obo/NCIT_C134745) (Stage I Hilar Cholangiocarcinoma AJCC v8), [NCIT:C134744](http://purl.obolibrary.org/obo/NCIT_C134744) (Stage 0 Hilar Cholangiocarcinoma AJCC v8), [NCIT:C134743](http://purl.obolibrary.org/obo/NCIT_C134743) (Hilar Cholangiocarcinoma by AJCC v8 Stage), [NCIT:C134764](http://purl.obolibrary.org/obo/NCIT_C134764) (Stage IV Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134742](http://purl.obolibrary.org/obo/NCIT_C134742) (Hilar Cholangiocarcinoma by AJCC v7 Stage), [NCIT:C8265](http://purl.obolibrary.org/obo/NCIT_C8265) (Adult Cholangiocarcinoma), [NCIT:C27325](http://purl.obolibrary.org/obo/NCIT_C27325) (Recurrent Cholangiocarcinoma), [NCIT:C96949](http://purl.obolibrary.org/obo/NCIT_C96949) (Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma), [NCIT:C88058](http://purl.obolibrary.org/obo/NCIT_C88058) (Stage 0 Hilar Cholangiocarcinoma AJCC v7), [NCIT:C88059](http://purl.obolibrary.org/obo/NCIT_C88059) (Stage I Hilar Cholangiocarcinoma AJCC v7), [NCIT:C36077](http://purl.obolibrary.org/obo/NCIT_C36077) (Hilar Cholangiocarcinoma), [NCIT:C88050](http://purl.obolibrary.org/obo/NCIT_C88050) (Stage I Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C88051](http://purl.obolibrary.org/obo/NCIT_C88051) (Stage II Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C134747](http://purl.obolibrary.org/obo/NCIT_C134747) (Stage III Hilar Cholangiocarcinoma AJCC v8), [NCIT:C134746](http://purl.obolibrary.org/obo/NCIT_C134746) (Stage II Hilar Cholangiocarcinoma AJCC v8), [NCIT:C88052](http://purl.obolibrary.org/obo/NCIT_C88052) (Stage III Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C96805](http://purl.obolibrary.org/obo/NCIT_C96805) (Peripheral Intrahepatic Cholangiocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.84%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40066](http://purl.obolibrary.org/obo/NCIT_C40066) (Undifferentiated Ovarian Sarcoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40063](http://purl.obolibrary.org/obo/NCIT_C40063) (Ovarian Low Grade Endometrioid Stromal Sarcoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40043](http://purl.obolibrary.org/obo/NCIT_C40043) (Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40041](http://purl.obolibrary.org/obo/NCIT_C40041) (Ovarian Mucinous Cystadenofibroma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40034](http://purl.obolibrary.org/obo/NCIT_C40034) (Ovarian Mucinous Adenocarcinofibroma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40032](http://purl.obolibrary.org/obo/NCIT_C40032) (Ovarian Serous Cystadenofibroma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40029](http://purl.obolibrary.org/obo/NCIT_C40029) (Borderline Ovarian Serous Cystadenofibroma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40021](http://purl.obolibrary.org/obo/NCIT_C40021) (Ovarian Lymphoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4002](http://purl.obolibrary.org/obo/NCIT_C4002) (Extraosseous Plasmacytoma))) 37.53%


